Want to see PTKFY full AI Analyst Report?
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $1.89B. The enterprise value is $1.78K.
Market Cap$1.89B
Enterprise Value$1.78K
Share Statistics
PT Kalbe Farma Tbk has 234,066,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding234,066,960
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.97%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)13.97%
Return on Capital Employed (ROCE)0.18
Revenue Per Employee2.75B
Profits Per Employee17.23K
Employee Count12,835
Asset Turnover1.15
Inventory Turnover3.04
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 9.1. PT Kalbe Farma Tbk’s PEG ratio is 0.91.
PE Ratio9.1
PS Ratio1.45
PB Ratio2.19
Price to Fair Value2.19
Price to FCF20.78
Price to Operating Cash Flow10.74
PEG Ratio0.91
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 35.32T and earned 3.66T in profits. Earnings per share was 16.18K.
Revenue35.32T
Gross Profit14.06T
Operating Income4.55T
Pretax Income4.78T
Net Income3.66T
EBITDA5.18T
Earnings Per Share (EPS)16.18K
Cash Flow
In the last 12 months, operating cash flow was 3.39T and capital expenditures -886.22B, giving a free cash flow of 2.50T billion.
Operating Cash Flow3.39T
Free Cash Flow2.50T
Free Cash Flow per Share10.68K
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.223, resulting in a dividend yield of 2.48%
Dividend Per Share$0.223
Dividend Yield2.48%
Payout Ratio23.13%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change-46.79%
50-Day Moving Average8.21
200-Day Moving Average11.56
Relative Strength Index (RSI)62.12
Average Volume (3m)154.00
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Nov 3, 2026, TBA (Confirmed).
Last Earnings DateJul 31, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
PT Kalbe Farma Tbk as a current ratio of 3.47, with Debt / Equity ratio of 3.40%
Current Ratio3.47
Quick Ratio2.16
Debt to Market Cap<0.01
Net Debt to EBITDA-0.78
Interest Coverage Ratio128.95
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 1.03T in taxes.
Income Tax1.03T
Effective Tax Rate0.22
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 9.09, with an EV/FCF ratio of 19.14.
EV to Sales1.33
EV to EBITDA9.09
EV to Free Cash Flow19.14
EV to Operating Cash Flow14.40
Balance Sheet
PT Kalbe Farma Tbk has $5.01T in cash and marketable securities with $829.84B in debt, giving a net cash position of $4.18T billion.
Cash & Marketable Securities$5.01T
Total Debt$829.84B
Net Cash$4.18T
Net Cash Per Share$17.84K
Tangible Book Value Per Share$98.92K
Margins
Gross margin is 37.52%, with operating margin of 12.87%, and net profit margin of 10.38%.
Gross Margin37.52%
Operating Margin12.87%
Pretax Margin13.53%
Net Profit Margin10.38%
EBITDA Margin14.66%
EBIT Margin13.63%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.85%
EPS Growth Forecast2.38%